S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
S&P 500   2,995.99 (-0.36%)
DOW   26,788.10 (-0.15%)
QQQ   191.85 (-0.80%)
AAPL   239.96 (-0.23%)
FB   182.34 (-3.91%)
MSFT   136.37 (-1.49%)
GOOGL   1,241.20 (-0.25%)
AMZN   1,765.73 (-1.12%)
CGC   21.15 (+3.93%)
NVDA   195.61 (-0.20%)
MU   44.66 (-1.24%)
BABA   169.89 (-2.09%)
GE   9.06 (+3.07%)
TSLA   255.58 (+0.82%)
AMD   31.51 (-1.62%)
T   38.17 (-0.16%)
F   9.07 (+0.44%)
ACB   3.58 (-2.98%)
PRI   125.80 (+0.09%)
NFLX   266.69 (-4.09%)
BAC   31.20 (+0.58%)
GILD   65.86 (+1.00%)
DIS   132.40 (+1.64%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Spark TherapeuticsChina Biologic ProductsRepligenAllogene TherapeuticsAblynx
SymbolNASDAQ:ONCENASDAQ:CBPONASDAQ:RGENNASDAQ:ALLON/A
Price Information
Current Price$100.20$114.99$79.04$27.96N/A
52 Week RangeHoldHoldBuyBuyN/A
Analyst Ratings
Consensus RecommendationHoldHoldBuyBuyN/A
Consensus Price Target$92.63$78.00$100.71$36.22N/A
% Upside from Price Target-7.55% downside-32.17% downside27.42% upside29.55% upsideN/A
Trade Information
Market Cap$3.88 billion$4.52 billion$4.04 billion$3.43 billion$3.81 billion
Beta2.071.21.14N/A1.99
Average Volume944,141186,363505,097419,537N/A
Sales & Book Value
Annual Revenue$64.72 million$466.88 million$194.03 millionN/A$62.73 million
Price / Sales59.589.6920.99N/A0.00
CashflowN/A$5.08 per share$1.13 per shareN/AN/A
Price / CashN/A22.6370.09N/AN/A
Book Value$13.15 per share$55.68 per share$14.03 per share$5.79 per share$2.71 per share
Price / Book7.622.075.63N/A0.00
Profitability
Net Income$-78,820,000.00$128.06 million$16.62 million$-211,510,000.00$-122,670,000.00
EPS($2.11)$4.02$0.73($6.58)N/A
Trailing P/E RatioN/A28.60108.27N/A0.00
Forward P/E RatioN/A30.5072.51N/AN/A
P/E GrowthN/A$7.02$4.08N/AN/A
Net Margins-397.68%29.46%11.42%N/AN/A
Return on Equity (ROE)-48.70%8.56%6.92%-31.00%N/A
Return on Assets (ROA)-29.57%7.86%5.54%-21.55%N/A
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio0.30%N/A0.02%0.05%N/A
Current Ratio5.56%10.57%2.25%13.46%N/A
Quick Ratio5.22%8.62%1.88%13.46%N/A
Ownership Information
Institutional Ownership Percentage86.41%36.90%86.50%54.49%N/A
Insider Ownership Percentage6.00%2.73%1.70%36.50%N/A
Miscellaneous
Employees3682,187548122N/A
Shares Outstanding38.49 million39.36 million51.53 million121.75 million75.25 million
Next Earnings Date11/5/2019 (Estimated)11/7/2019 (Estimated)11/7/2019 (Estimated)11/6/2019 (Estimated)N/A
OptionableOptionableOptionableOptionableNot OptionableNot Optionable
 Spark TherapeuticsChina Biologic ProductsRepligenAllogene TherapeuticsAblynx

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel